6QC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Towa Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 20.6 EUR

Market Cap: €1B

	Towa Pharmaceutical Co Ltd F:6QC	JP
	NEXE Innovations Inc F:NX5	CA
U	Ucb SA XBER:UNC	BE
C	Cathay Pacific Airways Ltd XMUN:CTY	HK
S	Suzuki Co Ltd XBER:SKI	JP
	Britannia Life Sciences Inc OTC:BLSIF	CA
P	Piquadro SpA XBER:4LZ	IT
	SOLAI Ltd OTC:SLAIY	US

Profitability Summary

Towa Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

36%

Sustainable 3Y Average Gross Margin

36%

Gross Margin is Increasing

35% > 36%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

4% > 9%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 3%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.